Methods for diagnosing and treating neuroendocrine cancer
AssigneeTrustees of Dartmouth College
InventorWilliam G. North
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for diagnosing neuroendocrine cancers via detecting the presence of N-methyl D-asparate-associated (NMDA) glutamate receptors type 1 and/or type 2. Methods for preventing and treating neuroendocrine cancers are also disclosed.
Claims1
A method for diagnosing small cell lung cancer (SCLC) or breast cancer comprising isolating a lung tissue sample or breast tissue sample from a subject, detecting the presence of at least one NMDA glutamate receptor protein in the lung tissue sample or breast tissue sample, and diagnosing the subject as having SCLC or breast cancer, respectively, when the presence of the at least one NMDA glutamate receptor protein is detected.
Dependencies are inferred from the claim text.